Novartis to cut more than 440 jobs in Britain

Swiss pharmaceuticals giant Novartis said Wednesday it aimed to slash more than 440 jobs in Britain, blaming industry-wide difficulties.

Novartis is considering closing its manufacturing site in Horsham, West Sussex, which would lead to the evaporation of 371 jobs, the told AFP in an email, confirming a report by the FierceBiotech website.

The closure was needed as Novartis attempts to adapt to "a challenging healthcare marketplace," it said, stressing that the decision was still subject to consultations with employees and final approval by its UK board.

"We understand that this will be a difficult time for potentially affected employees, their families and the wider Horsham community given the links the company has in the area," Novartis said, vowing to do its utmost to "make the process as straightforward and smooth as possible."

Two years ago, Novartis announced plans to halt manufacturing at the site and to cut staff numbers there from 950 to 450 people, but the group said Wednesday it now also aimed to close a unit dedicated to .

Novartis also said that cuts at its UK pharmaceuticals division in Frimley, Surrey, could impact another 72 .

The company currently employs more than 3,000 people in Britain.

add to favorites email to friend print save as pdf

Related Stories

Novartis announces 2,000 job losses, profits up

Oct 25, 2011

Swiss pharmaceutical giant Novartis announced 2,000 job losses Tuesday, mostly in Switzerland and the United States, while reporting net profits of $3.53 billion (2.5 billion euros) for the third quarter.

Recommended for you

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments